HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Commentary regarding: A randomized trial of icatibant in ACE-inhibitor-induced angioedema.

AuthorsKim B Yancey
JournalDermatologic therapy (Dermatol Ther) 2015 Sep-Oct Vol. 28 Issue 5 Pg. 331 ISSN: 1529-8019 [Electronic] United States
PMID25818322 (Publication Type: Journal Article, Comment)
Chemical References
  • Angiotensin-Converting Enzyme Inhibitors
  • Bradykinin B2 Receptor Antagonists
  • Bradykinin
Topics
  • Angioedema (drug therapy)
  • Angiotensin-Converting Enzyme Inhibitors (adverse effects)
  • Bradykinin (analogs & derivatives)
  • Bradykinin B2 Receptor Antagonists (therapeutic use)
  • Female
  • Humans
  • Male

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: